Developer docs
API playgroundTry for free, no card

Search company profiles

HTANALYSTS

Full company profile

uuid002me9e

Namestring
HTANALYSTS
Legal namestring
Health Technology Analysts
Company typeenum
Private
Founded yearint
2002
Descriptiontext

HTANALYSTS (legally Health Technology Analysts) is an Australian healthcare consultancy founded in 2002 and headquartered in Surry Hills, NSW, that specialises in health technology assessment (HTA), health economics and outcomes research (HEOR), patient engagement, and social impact measurement. The firm serves pharmaceutical, biotechnology, medical technology, government, and not-for-profit clients in Australia and New Zealand, with services spanning reimbursement submissions to PBAC, MSAC, PHARMAC, and ATAGI; market access strategy; systematic reviews and clinical guideline development; economic modelling; and Social Return on Investment (SROI) analysis delivered through both Premium (end-to-end) and Coached (capability-building) offerings. Its technical differentiator is the proprietary Ripple collaboration platform, a secure outcomes-tracking and team collaboration tool built on Google authentication and security infrastructure, which underpins SROI Coached engagements on a tiered subscription model.

The business operates a professional services revenue model with quote-based project pricing, complemented by structured SROI Coached packages starting at AUD $50,000 for a first project and AUD $100-$300 monthly platform fees for multi-project tiers. Go-to-market is enterprise sales-led, reaching clients through direct business development, professional networks, thought leadership content, and partnerships with bodies such as ISPOR Australian Chapter (including co-hosting the July 2026 AI in Health Innovation event). The firm is privately held following a 2016 management buy-out by owners Alasdair Godfrey (Chief Medical Officer) and Colman Taylor (Chief Vision Officer, Conjoint Associate Professor at UNSW), with a 30+ specialist team supported by a documented track record of 500+ projects, 100+ reimbursement submissions, 70+ systematic reviews, and 50+ peer-reviewed publications. The company also runs a Training Programmes division covering HTA, HEOR, market access, patient engagement, and SROI methodology, delivered in-person or online to clients across APAC.

Short descriptiontext

HTANALYSTS is an Australian healthcare consultancy providing health technology assessment, HEOR, patient engagement, and SROI impact measurement services to pharmaceutical, medtech, government, and not-for-profit clients across Australia and New Zealand. Founded in 2002, the firm delivers reimbursement submissions, market access strategy, and economic modelling supported by its proprietary Ripple collaboration platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSurry Hills, Australia
HQ citystring
Surry Hills
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health technology assessment, health economics consulting, patient engagement services, social impact measurement, market access consulting
Industry3 codes
PRIMARYHLAIAKAD
Payer & HTA Engagement (Reimbursement/Submissions)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAJANAL
Economic Evaluation & Health Technology Assessment (Public Programs)
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Marketing Research and Public Opinion Polling54191
SIC code2 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
Product category
Healthcare Consulting
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Health Technology Assessment & HEOR Consulting
TypeProfessional Services
Description

Professional consulting services providing health economic evaluation, evidence synthesis, reimbursement submissions (PBAC, MSAC, PHARMAC), market access strategy, and health technology assessment to support funding, policy, and market access decisions.

htanalysts.com.au
2Social Impact Assessment Services
TypeProfessional Services
Description

SROI (Social Return on Investment) assessment services including Premium (end-to-end delivery) and Coached (capability building support) offerings, along with broader impact assessments for healthcare programmes and government initiatives.

htanalysts.com.au
3Healthcare Training Programmes
TypeProfessional Services
Description

Expert-led training in HTA, HEOR, market access, patient engagement, and SROI delivered through modular workshops, bespoke programmes, and online learning. Training is offered to pharmaceutical companies, government organisations, healthcare providers, and not-for-profits.

htanalysts.com.au
4Patient Engagement Services
TypeProfessional Services
Description

Centre of Excellence for Patient Engagement providing advisory boards, patient interviews, journey mapping, support programme design, and advocacy-ready insights to strengthen HTA submissions and policy decisions.

htanalysts.com.au
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details3 tiers
1SROI Coached - 1st Project
ModelOtherBilling cadenceMulti-year contract
Notes

Service fee: $50,000 for first project. Includes access to Ripple collaboration platform free of charge. Coaching approach where HTANALYSTS supports client's team through the SROI process.

htanalysts.com.au
2SROI Coached - Up to 5 Projects
ModelOtherBilling cadenceMulti-year contract
Notes

Service fee tailored to client needs. Access to Ripple: $100 per month. Suitable for organisations conducting multiple SROI assessments.

htanalysts.com.au
3SROI Coached - Up to 50 Projects
ModelOtherBilling cadenceMulti-year contract
Notes

Service fee tailored to client needs. Access to Ripple: $300 per month. Designed for organisations with high-volume SROI assessment requirements.

htanalysts.com.au
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Ripple
Description

A powerful and secure collaboration platform that helps track outcomes and drive progress, leveraging Google's security and authentication protocols.

htanalysts.com.au
Core offering1 text field

HTANALYSTS is a healthcare consultancy delivering health technology assessment (HTA), health economics and outcomes research (HEOR), market access strategy, and reimbursement submission services to pharmaceutical, medical technology, government, and not-for-profit clients. The firm also provides social impact assessment services (including Social Return on Investment), patient engagement advisory through its Centre of Excellence, and structured healthcare training programmes. Its proprietary Ripple collaboration platform supports project delivery and team coordination across these engagements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over $3 billion in projected value from new model of care for cardiovascular disease management
+4 more records
Product overview1 text field

HTANALYSTS is a leading Australian healthcare consultancy specialising in health technology assessment (HTA), health economics and outcomes research (HEOR), patient engagement, and social impact assessment. The firm operates a portfolio of service offerings built around its core consulting capabilities: Healthcare Services (encompassing evidence evaluation, reimbursement submissions to PBAC/MSAC/PHARMAC, market access strategy, and economic modelling); a dedicated Patient Engagement Centre of Excellence providing advisory boards, journey mapping, and lived experience insights; Social Impact Assessment Services including SROI Premium (full end-to-end assessment) and SROI Coached (capability-building support); the proprietary Ripple collaboration platform for managing impact projects; APAC Training Programmes for building HTA/HEOR/market access skills; and specialist practices in Sustainability, Government Advisory, and Healthy Ageing. These offerings are designed to work synergistically—Ripple underpins SROI delivery, patient engagement strengthens HTA submissions, and training builds market access capability—forming an integrated suite supporting funding, policy, and healthcare decision-making.

Product and service10 records
1SROI Premium
CategorySocial Impact Services
2SROI Coached
CategorySocial Impact Services
3Ripple Collaboration Platform
CategorySoftware Platform
4Healthcare Consulting Services
CategoryHealthcare Consulting
5Patient Engagement Services
CategoryPatient Engagement Services
6Social Impact Assessment Services
CategorySocial Impact Services
7APAC Training Programmes
CategoryTraining and Education
8Sustainability Services
CategorySustainability Consulting
9Government Advisory Services
CategoryGovernment Consulting
10Healthy Ageing Services
CategoryHealthcare Consulting
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-22
Description

HTANALYSTS has partnered with ISPOR Australian Chapter to co-host the AI in Health Innovation event (July 2026, Sydney). This partnership brings together leading experts across government, industry, and academia to examine AI in health technology assessment, featuring speakers including Prof Toby Walsh, Prof Andrew Wilson, Prof Paul Glasziou, Prof Chris Bain, and Megan Lloyd.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Commissioned by Thermo Fisher Scientific to conduct modelling assessing the value of rapid Next-Generation Sequencing (NGS) from both health system and patient perspectives. Analysis focused on non-small cell lung cancer (NSCLC) demonstrating cost savings and improved outcomes.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Collaborated with Novartis Pharmaceuticals and other organisations to co-design a new cardiovascular disease management model (TEST, TREAT, TRACK). HTANALYSTS conducted impact assessment estimating over $3 billion in projected value.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Independent UK-based health economics and market access consultancy providing HTA submissions, evidence reviews, and economic modelling to pharma and medtech clients. Closely comparable boutique-scale HTA peer.

TypeRegional player
Description

Australian health data analytics and real-world evidence company. Regional peer serving Australian pharma and government on market access and evidence generation, overlapping with HTANALYSTS' analytics-heavy work.

TypeBroad incumbent
Description

Global healthcare data, analytics, and consulting powerhouse. Its Real-World Evidence and HEOR practices compete for the same reimbursement submission and market access budgets as HTANALYSTS but at vastly greater scale and with global delivery capacity.

TypeBroad incumbent
Description

Large global CRO with dedicated market access and HEOR consulting. Competes for HTA submission work via larger, integrated clinical-plus-commercial engagements.

TypeBroad incumbent
Description

Global consulting firm with a Life Sciences practice offering HEOR, market access, and pricing strategy to pharma and biotech. Broad incumbent offering comparable reimbursement strategy services.

TypeDirect peer
Description

Pure-play HTA, HEOR, and market access consultancy (now part of Thermo Fisher Scientific's PPD). Closest direct competitor — offers the same reimbursement submission, evidence synthesis, and economic modelling services to pharma and medtech sponsors across global markets.

TypeDirect peer
Description

Non-profit HEOR and market access consultancy providing evidence synthesis, economic modelling, and patient-centred research to pharma and device manufacturers. Direct services overlap with HTANALYSTS' HEOR and HTA submission work.

TypeDirect peer
Description

UK health economics and market access consultancy delivering HTA submissions (NICE, SMC, NCPE), evidence generation, and patient involvement services. Comparable boutique HTA peer with similar service breadth to HTANALYSTS.

TypeEmerging player
Description

Specialist market access consultancy supporting pharma and medtech clients with HTA submissions and value communication. Emerging boutique peer with similar service positioning.

TypeDirect peer
Description

Norwegian health economics and HTA consultancy providing economic evaluations, reimbursement support, and market access services. Comparable boutique peer with similar service portfolio to HTANALYSTS.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HTANALYSTS

Healthcare Consultinghtanalysts.com.au

HTANALYSTS is an Australian healthcare consultancy providing health technology assessment, HEOR, patient engagement, and SROI impact measurement services to pharmaceutical, medtech, government, and not-for-profit clients across Australia and New Zealand. Founded in 2002, the firm delivers reimbursement submissions, market access strategy, and economic modelling supported by its proprietary Ripple collaboration platform.

What HTANALYSTS does

HTANALYSTS (legally Health Technology Analysts) is an Australian healthcare consultancy founded in 2002 and headquartered in Surry Hills, NSW, that specialises in health technology assessment (HTA), health economics and outcomes research (HEOR), patient engagement, and social impact measurement. The firm serves pharmaceutical, biotechnology, medical technology, government, and not-for-profit clients in Australia and New Zealand, with services spanning reimbursement submissions to PBAC, MSAC, PHARMAC, and ATAGI; market access strategy; systematic reviews and clinical guideline development; economic modelling; and Social Return on Investment (SROI) analysis delivered through both Premium (end-to-end) and Coached (capability-building) offerings. Its technical differentiator is the proprietary Ripple collaboration platform, a secure outcomes-tracking and team collaboration tool built on Google authentication and security infrastructure, which underpins SROI Coached engagements on a tiered subscription model.

The business operates a professional services revenue model with quote-based project pricing, complemented by structured SROI Coached packages starting at AUD $50,000 for a first project and AUD $100-$300 monthly platform fees for multi-project tiers. Go-to-market is enterprise sales-led, reaching clients through direct business development, professional networks, thought leadership content, and partnerships with bodies such as ISPOR Australian Chapter (including co-hosting the July 2026 AI in Health Innovation event). The firm is privately held following a 2016 management buy-out by owners Alasdair Godfrey (Chief Medical Officer) and Colman Taylor (Chief Vision Officer, Conjoint Associate Professor at UNSW), with a 30+ specialist team supported by a documented track record of 500+ projects, 100+ reimbursement submissions, 70+ systematic reviews, and 50+ peer-reviewed publications. The company also runs a Training Programmes division covering HTA, HEOR, market access, patient engagement, and SROI methodology, delivered in-person or online to clients across APAC.

HTANALYSTS firmographics

Firmographics
Name
HTANALYSTS
Legal name
Health Technology Analysts
Website
https://htanalysts.com.au
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
HTANALYSTS is an Australian healthcare consultancy providing health technology assessment, HEOR, patient engagement, and SROI impact measurement services to pharmaceutical, medtech, government, and not-for-profit clients across Australia and New Zealand. Founded in 2002, the firm delivers reimbursement submissions, market access strategy, and economic modelling supported by its proprietary Ripple collaboration platform.
Ownership category
akta.pro rank

HTANALYSTS industry classification

Industry
Product category
Healthcare Consulting
NAICS
Marketing Research and Public Opinion Polling (54191)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAIAKAD
Payer & HTA Engagement (Reimbursement/Submissions)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAJANAL
Economic Evaluation & Health Technology Assessment (Public Programs)
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Health technology assessment
  • Health economics consulting
  • Patient engagement services
  • Social impact measurement
  • Market access consulting

Where HTANALYSTS is headquartered

Location

Headquarters

HQ city
Surry Hills
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

HTANALYSTS business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Health Technology Assessment & HEOR Consulting: Professional consulting services providing health economic evaluation, evidence synthesis, reimbursement submissions (PBAC, MSAC, PHARMAC), market access strategy, and health technology assessment to support funding, policy, and market access decisions.
  2. Social Impact Assessment Services: SROI (Social Return on Investment) assessment services including Premium (end-to-end delivery) and Coached (capability building support) offerings, along with broader impact assessments for healthcare programmes and government initiatives.
  3. Healthcare Training Programmes: Expert-led training in HTA, HEOR, market access, patient engagement, and SROI delivered through modular workshops, bespoke programmes, and online learning. Training is offered to pharmaceutical companies, government organisations, healthcare providers, and not-for-profits.
  4. Patient Engagement Services: Centre of Excellence for Patient Engagement providing advisory boards, patient interviews, journey mapping, support programme design, and advocacy-ready insights to strengthen HTA submissions and policy decisions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractSROI Coached - 1st Project
OtherMulti-year contractSROI Coached - Up to 5 Projects
OtherMulti-year contractSROI Coached - Up to 50 Projects

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

HTANALYSTS product offering

Product offering

Core offering

HTANALYSTS is a healthcare consultancy delivering health technology assessment (HTA), health economics and outcomes research (HEOR), market access strategy, and reimbursement submission services to pharmaceutical, medical technology, government, and not-for-profit clients. The firm also provides social impact assessment services (including Social Return on Investment), patient engagement advisory through its Centre of Excellence, and structured healthcare training programmes. Its proprietary Ripple collaboration platform supports project delivery and team coordination across these engagements.

Product overview

HTANALYSTS is a leading Australian healthcare consultancy specialising in health technology assessment (HTA), health economics and outcomes research (HEOR), patient engagement, and social impact assessment. The firm operates a portfolio of service offerings built around its core consulting capabilities: Healthcare Services (encompassing evidence evaluation, reimbursement submissions to PBAC/MSAC/PHARMAC, market access strategy, and economic modelling); a dedicated Patient Engagement Centre of Excellence providing advisory boards, journey mapping, and lived experience insights; Social Impact Assessment Services including SROI Premium (full end-to-end assessment) and SROI Coached (capability-building support); the proprietary Ripple collaboration platform for managing impact projects; APAC Training Programmes for building HTA/HEOR/market access skills; and specialist practices in Sustainability, Government Advisory, and Healthy Ageing. These offerings are designed to work synergistically—Ripple underpins SROI delivery, patient engagement strengthens HTA submissions, and training builds market access capability—forming an integrated suite supporting funding, policy, and healthcare decision-making.

Differentiator

Problem solved

Functional benefit

Brands

  • Ripple: A powerful and secure collaboration platform that helps track outcomes and drive progress, leveraging Google's security and authentication protocols.

Products and services

  • SROI Premium
  • SROI Coached
  • Ripple Collaboration Platform
  • Healthcare Consulting Services
  • Patient Engagement Services
  • Social Impact Assessment Services
  • APAC Training Programmes
  • Sustainability Services
  • Government Advisory Services
  • Healthy Ageing Services

Quantifiable outcome

  • Over $3 billion in projected value from new model of care for cardiovascular disease management
  • +4 more outcomes

Companies that use HTANALYSTS

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles5 records

HTANALYSTS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

HTANALYSTS partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and key.

  • ISPOR Australian ChaptercoreStrategic or Co-development Partner · 22 July 2026HTANALYSTS has partnered with ISPOR Australian Chapter to co-host the AI in Health Innovation event (July 2026, Sydney). This partnership brings together leading experts across government, industry, and academia to examine AI in health technology assessment, featuring speakers including Prof Toby Walsh, Prof Andrew Wilson, Prof Paul Glasziou, Prof Chris Bain, and Megan Lloyd.
  • Thermo Fisher ScientifickeyStrategic or Co-development PartnerCommissioned by Thermo Fisher Scientific to conduct modelling assessing the value of rapid Next-Generation Sequencing (NGS) from both health system and patient perspectives. Analysis focused on non-small cell lung cancer (NSCLC) demonstrating cost savings and improved outcomes.
  • Novartis PharmaceuticalskeyStrategic or Co-development PartnerCollaborated with Novartis Pharmaceuticals and other organisations to co-design a new cardiovascular disease management model (TEST, TREAT, TRACK). HTANALYSTS conducted impact assessment estimating over $3 billion in projected value.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

HTANALYSTS competitors and assessment

Company assessment

Direct peers

  • Source Health Economics: Independent UK-based health economics and market access consultancy providing HTA submissions, evidence reviews, and economic modelling to pharma and medtech clients. Closely comparable boutique-scale HTA peer.
  • Evidera: Pure-play HTA, HEOR, and market access consultancy (now part of Thermo Fisher Scientific's PPD). Closest direct competitor — offers the same reimbursement submission, evidence synthesis, and economic modelling services to pharma and medtech sponsors across global markets.
  • RTI Health Solutions: Non-profit HEOR and market access consultancy providing evidence synthesis, economic modelling, and patient-centred research to pharma and device manufacturers. Direct services overlap with HTANALYSTS' HEOR and HTA submission work.
  • Mtech Access: UK health economics and market access consultancy delivering HTA submissions (NICE, SMC, NCPE), evidence generation, and patient involvement services. Comparable boutique HTA peer with similar service breadth to HTANALYSTS.
  • THEMA Consulting: Norwegian health economics and HTA consultancy providing economic evaluations, reimbursement support, and market access services. Comparable boutique peer with similar service portfolio to HTANALYSTS.

Regional players

  • Prospection: Australian health data analytics and real-world evidence company. Regional peer serving Australian pharma and government on market access and evidence generation, overlapping with HTANALYSTS' analytics-heavy work.

Broad incumbents

  • IQVIA: Global healthcare data, analytics, and consulting powerhouse. Its Real-World Evidence and HEOR practices compete for the same reimbursement submission and market access budgets as HTANALYSTS but at vastly greater scale and with global delivery capacity.
  • PAREXEL International: Large global CRO with dedicated market access and HEOR consulting. Competes for HTA submission work via larger, integrated clinical-plus-commercial engagements.
  • Charles River Associates: Global consulting firm with a Life Sciences practice offering HEOR, market access, and pricing strategy to pharma and biotech. Broad incumbent offering comparable reimbursement strategy services.

Emerging players

  • Valid Insight: Specialist market access consultancy supporting pharma and medtech clients with HTA submissions and value communication. Emerging boutique peer with similar service positioning.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

HTANALYSTS social profiles

Digital presence

HTANALYSTS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HTANALYSTS leadership team

Management profile

Number of profiles

Profiles11 records

HTANALYSTS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HTANALYSTS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HTANALYSTS

What does HTANALYSTS do?

HTANALYSTS is a healthcare consultancy delivering health technology assessment (HTA), health economics and outcomes research (HEOR), market access strategy, and reimbursement submission services to pharmaceutical, medical technology, government, and not-for-profit clients. The firm also provides social impact assessment services (including Social Return on Investment), patient engagement advisory through its Centre of Excellence, and structured healthcare training programmes. Its proprietary Ripple collaboration platform supports project delivery and team coordination across these engagements.

Is HTANALYSTS a public or private company?

HTANALYSTS is a private company. It is classified as management employee owned and is currently operating.

When was HTANALYSTS founded?

HTANALYSTS was founded in 2002. It employs 11 to 50 people.

Where is HTANALYSTS based?

HTANALYSTS is headquartered in Surry Hills, Australia, in the Oceania region.

How does HTANALYSTS make money?

Four revenue lines are on record. Health Technology Assessment & HEOR Consulting is the primary driver. The others are social Impact Assessment Services, healthcare Training Programmes and patient Engagement Services.

Who are HTANALYSTS's main competitors?

Direct peers on record are Source Health Economics, Evidera, RTI Health Solutions, Mtech Access and THEMA Consulting. Prospection is listed as a regional player. Broad incumbents are IQVIA, PAREXEL International and Charles River Associates. Valid Insight is listed as an emerging player.

Does HTANALYSTS have an API?

No public API is recorded for HTANALYSTS.

What industry is HTANALYSTS in?

HTANALYSTS's product category is Healthcare Consulting. Its primary akta.pro industry code is HLAIAKAD, Payer & HTA Engagement (Reimbursement/Submissions), with a secondary code of HLAJANAL, Economic Evaluation & Health Technology Assessment (Public Programs). Its NAICS code is 54191 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals